Lupo, J.; Wielandts, A.-S.; Buisson, M.; Consortium, C.; Habib, M.; Hamoudi, M.; Morand, P.; Verduyn-Lunel, F.; Caillard, S.; Drouet, E.
High Predictive Value of the Soluble ZEBRA Antigen (Epstein-Barr Virus Trans-Activator Zta) in Transplant Patients with PTLD. Pathogens 2022, 11, 928.
https://doi.org/10.3390/pathogens11080928
AMA Style
Lupo J, Wielandts A-S, Buisson M, Consortium C, Habib M, Hamoudi M, Morand P, Verduyn-Lunel F, Caillard S, Drouet E.
High Predictive Value of the Soluble ZEBRA Antigen (Epstein-Barr Virus Trans-Activator Zta) in Transplant Patients with PTLD. Pathogens. 2022; 11(8):928.
https://doi.org/10.3390/pathogens11080928
Chicago/Turabian Style
Lupo, Julien, Anne-Sophie Wielandts, Marlyse Buisson, CRYOSTEM Consortium, Mohammed Habib, Marwan Hamoudi, Patrice Morand, Frans Verduyn-Lunel, Sophie Caillard, and Emmanuel Drouet.
2022. "High Predictive Value of the Soluble ZEBRA Antigen (Epstein-Barr Virus Trans-Activator Zta) in Transplant Patients with PTLD" Pathogens 11, no. 8: 928.
https://doi.org/10.3390/pathogens11080928
APA Style
Lupo, J., Wielandts, A.-S., Buisson, M., Consortium, C., Habib, M., Hamoudi, M., Morand, P., Verduyn-Lunel, F., Caillard, S., & Drouet, E.
(2022). High Predictive Value of the Soluble ZEBRA Antigen (Epstein-Barr Virus Trans-Activator Zta) in Transplant Patients with PTLD. Pathogens, 11(8), 928.
https://doi.org/10.3390/pathogens11080928